IVZ Cash Flow Statement

Click line-items for a historical chart and %
Operating activities:
Net income 199.6M
Adjustments to reconcile net income to net cash used in operating activities:
Amortization and depreciation 22.3M
Share-based compensation expense 33.5M
Purchase of trading investments -3.41B
Proceeds from sale of trading investments 3.4B
Other gains and losses, net -17.7M
(Gains)/losses of consolidated investment products, net 21.1M
Tax benefit from share-based compensation 47.7M
Excess tax benefits from share-based compensation -11.7M
Equity in earnings of unconsolidated affiliates -8.1M
Dividends from unconsolidated affiliates 1M
Changes in operating assets and liabilities:
(Increase)/decrease in cash held by consolidated investment products -470.2M
(Increase)/decrease in receivables -606.6M
Increase/(decrease) in payables 317.8M
Net cash provided by/(used in) operating activities -484.6M
Investing activities:
Purchase of property and equipment -18.1M
Purchase of available-for-sale investments -100K
Proceeds from sale of available-for-sale investments
Purchase of investments by consolidated investment products -965.2M
Proceeds from sale of investments by consolidated investment products 1.21B
Returns of capital in investments of consolidated investment products
Purchase of other investments -127.9M
Proceeds from sale of other investments 25.3M
Returns of capital and distributions from unconsolidated partnership investments 3.8M
Acquisition of businesses
Acquisition earn-out payments 0
Net cash provided by/(used in) investing activities 146.4M
Financing activities:
Proceeds from exercises of share options 5.2M
Purchases of treasury shares -45M
Dividends paid -77.2M
Excess tax benefits from share-based compensation 11.7M
Capital invested into consolidated investment products 3.5M
Capital distributed by consolidated investment products -60.9M
Repayments of debt of consolidated investment products 253M
Net borrowings/(repayments) under credit facility 328.5M
Acquisition of interest in consolidated investment products
Net cash (used in)/provided by financing activities 418.8M
(Decrease)/increase in cash and cash equivalents 80.6M
Foreign exchange movement on cash and cash equivalents -31.4M
Cash and cash equivalents, beginning of period 835.5M
Cash and cash equivalents, end of period 884.7M
Supplemental Cash Flow Information:
Interest paid -2.6M
Interest received 1.3M
Taxes paid -41.3M